covid fda - Search News

Order byBest matchMost fresh

FDA, COVID and vaccine

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

Vaccine manufacturers will need to conduct "randomized, placebo-controlled trials" before the FDA will approve future applications to give shots to "all healthy persons" between the ages of 6 months ...

· 1d · on MSN

· 18h

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

· 1d · on MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

FDA’s new approach to covid vaccines could have been way worse

Older adults can continue getting covid boosters, but not everyone who wants them can.

· 1d

· 14h

FDA panel recommends keeping COVID shots targeted to same strain as last year

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 18h

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

· 20h

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

10hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,

22h

FDA won’t approve COVID shot for healthy, non-elderly population

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

18h

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat

2don MSN

FDA sets new requirements for COVID vaccines in healthy adults and children

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy

13hon MSN

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of recommending that COVID-19 vaccines for 2025-26 should target newer strains of the JN.1 variant.

10hon MSN

Trump's FDA Has Axed COVID Boosters For Most People — And Medical Experts Are Deeply Worried

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.

3don MSN

FDA to Unveil Covid Shot Policy as RFK Jr. Eyes More Tests

President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.